Lipid-lowering drugs in heterozygous familial hypercholesterolaemia: a 15-year clinical history
Dear EditorHeterozygous familial hypercholesterolaemia (HeFH) is an autosomal dominant metabolic disorder characterised by impaired low-density lipoprotein receptor (LDLR) function, leading to redu...
Authors
- Francesco Sbrana (ORCID: https://orcid.org/0000-0003-4607-0373)
- Beatrice Dal Pino
Institutions
- Fondazione Toscana Gabriele Monasterio (IT)
Publication Details
- Journal
- Acta cardiologica. Supplementum
- Published
- 2026-09-08
- DOI
- https://doi.org/10.1080/00015385.2026.2725434
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00